According to a new report, published by KBV research, The Global Mobile ECG Devices Market size is expected to reach $5.1 billion by 2030, rising at a market growth of 12.2% CAGR during the forecast period. In the year 2022, the market attained a volume of 8,492.6 thousand units, experiencing a growth of 17.5% (2019-2022).
The Handheld segment is leading the Global Mobile ECG Devices Market, by Modality in 2022 thereby achieving a market value of $2.3 Billion by 2030. Its seamless blend of functionality and portability is the main reason for the segment's growth. For patients and medical professionals, these devices provide a workable solution that guarantees ease of use without sacrificing the accuracy needed for ECG monitoring. With their sophisticated features, user-friendly interfaces, and wireless connectivity options, handheld devices are more versatile and adaptable in a range of healthcare environments. Additionally, a broad range of users can utilize them due to their user-friendly design and ergonomics, which further solidifies their appeal and broad market adoption.
The Hospitals & Diagnostic Centers segment would display a CAGR of 11.7 % during the forecast period. Hospitals and diagnostic centers can use mobile ECG devices for patient outreach and education. Providing patients with these devices can serve as a way to educate them about heart health, self-monitoring, and the importance of regular check-ups. Mobile ECG devices often come with cloud-based platforms for data storage and analysis. Healthcare professionals can access and review historical ECG data, track trends, and make informed decisions about patient care. This analytical capability supports better patient management.
The North America region dominated the Global Mobile ECG Devices Market, by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2.2 Billion by 2030. The Europe market is poised to grow at a CAGR of 11.8% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 13.2% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/mobile-ecg-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of New York Plastic Surgical Group, PC (Long Island Plastic Surgical Group), Nihon Kohden Corporation, GE HealthCare Technologies, Inc., Medtronic PLC, iRhythm Technologies, Inc., Koninklijke Philips N.V., OMRON Corporation, Nureca Limited (Dr Trust), EMAY, and AliveCor, Inc.
By Modality (Volume, Thousand Units, USD Billion, 2019-2030)
By End-use (Volume, Thousand Units, USD Billion, 2019-2030)
By Geography (Volume, Thousand Units, USD Billion, 2019-2030)
Companies Profiled
Unique Offerings 
